Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized for You
we will pick new questions that match your level based on your Timer History
Track Your Progress
every week, we’ll send you an estimated GMAT score based on your performance
Practice Pays
we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
From the mid-1980s through the early-2000s, specialty substance abuse centers, facilities that provide both residential and outpatient treatment services, emerged as dominant players in national substance abuse treatment. During the early to mid-1990s, expensive inpatient and residential treatment, viewed as less cost effective than intensive outpatient treatment models, were targeted as an area for cost-cutting, particularly for private insurance.
Concurrently, and throughout this time period, sales of prescription drugs have remained a minor portion of spending for substance abuse treatment. Only a few drugs are available to treat substance disorders. In 2004, acamprosate joined two, other previously FDA approved medications–disulfiram and naltrexone–for the treatment of alcoholism. Buprenorphine for the for the treatment of opiate addiction was approved in 2002. Methadone for treatment of opioid addiction is not available as a retail prescription drug and spending for methadone is included with specialty substance abuse centers.
The substance abuse public payer mix is expected to shift toward programs that are wholly or partially funded by state and local governments.
Other state and local spending is expected to continue to increase as a share of substance abuse spending throughout the projection period, rising from a 29 percent share in 1986 and a 40 percent share in 2003 to a projected 42 percent share in 2006 and 45 percent share in 2014 as reflected in the figure below.
It can be inferred from the information in the tabs that the entities most likely to benefit from increased governmental subsidies for the projected period would be??????
It can be inferred from the information in the tabs that the entities most likely to benefit from increased governmental subsidies for the projected period would be??????
FDA-approved pharmaceutical companies
in-patient and residential treatment facilities
Medicare and Medicaid recipients
private insurers
specialty substance abuse centers
Show more
In tab 1, it is stated that "from the mid-1980s through the early-2000s, specialty substance abuse centers, emerged as dominant players in national substance abuse treatment," so it can be reasonably inferred that these entities would be most likely to benefit from increased spending on substance abuse treatment through governmental subsidies.
Correct answer: It can be inferred from the information in the tabs that the entities most likely to benefit from increased governmental subsidies for the projected period would be??????: specialty substance abuse centers